Concurrent chemotherapy and radiation therapy for locally advanced cervical cancer

被引：0
|
作者：
Roth, B [1 ]
机构：
[1] Univ Buenos Aires, Inst Oncol, Chairman Dept Radiat Oncol, RA-1053 Buenos Aires, DF, Argentina
来源：
GYNECOLOGIC ONCOLOGY ISSUES IN THE 8TH IGCS MEETING OF BUENOS AIRES | 2000年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cervical cancer is the principal cause of death due to cancer in women. advances in treatment of solid tumors are made slowly. Since the NCI announced the principal recommendations, the place of radiochemiotherapy in the treatment of ca cervix. The combination of radiotheraphy with hydroxyurea, or RT with Cisplatin and 5-Fluorouracil in treatments. Concominant radiochemotherapy based on cisplatin at one or in combination with 5fu can be considered standard treatment for stages IB, IIA, proximal IIB; with bad prognostic factors (t > 4cm invasion of pelvic nodes, microscopic invasion of the parametrium) and without lumboaortic invasion.
引用
收藏
页码：53 / 55
页数：3
相关论文
共 50 条
  • [21] Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer
    Eifel, PJ
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 248 - 255
  • [22] Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer
    Patricia J Eifel
    [J]. Nature Clinical Practice Oncology, 2006, 3 : 248 - 255
  • [23] Safety and efficacy of nimotuzumab and concurrent intensity-modulated radiation therapy and chemotherapy for locally advanced cervical squamous cell cancer.
    Qu, Ang
    Wang, Junjie
    Jiang, Ping
    Wang, Panfeng
    Zhang, Muyi
    Li, Xu
    Sun, Haitao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
    Rose, PG
    Bundy, BN
    Watkins, EB
    Thigpen, JT
    Deppe, G
    Maiman, MA
    Clarke-Pearson, DL
    Insalaco, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15): : 1144 - 1153
  • [25] Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?
    Lehman, M
    Thomas, G
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (02) : 87 - 99
  • [26] Phase I trial of nelfinavir added to cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
    Garcia-Soto, A. E.
    McKenzie, N. D.
    Pearson, J. M.
    Portelance, L.
    Lucci, J. A., III
    Lin, L. L.
    Simpkins, F.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 267 - 268
  • [27] Adjuvant Carboplatin and Paclitaxel after Concurrent Cisplatin and Radiation Therapy in Patients with Locally Advanced Cervical Cancer
    Yavas, G.
    Yavas, C.
    Sen, E.
    Oner, I.
    Celik, C.
    Ata, O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S221 - S221
  • [28] Concurrent radio-chemotherapy for locally advanced cervical cancer: The comparison of two chemotherapy regimens
    Nagy, Viorica
    Ordeanu, Claudia
    Coza, Ovidiu
    Todor, Nicolae
    Ghilezan, Nicolae
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 134 - 134
  • [29] Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer
    Magnino, A
    Gatti, M
    Massucco, P
    Sperti, E
    Faggiuolo, R
    Regge, D
    Capussotti, L
    Gabriele, P
    Aglietta, M
    [J]. ONCOLOGY, 2005, 68 (4-6) : 493 - 499
  • [30] Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer
    Rosenzweig, Kenneth E.
    Gomez, Jorge E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) : 6 - +
12345